title: Weekend therapy in diabetes.
abstract: This article introduces the concept of "weekend therapy", which has now become reality in diabetes. It briefly describes injectable and oral drugs which are currently available, or are in advanced stages of development, for use in once weekly administration. These include dulaglutide, exenatide QW, semaglutide, omarigliptin and trelagliptin.
authors.affiliation: Department of Endocrinology, Bharti Hospital, Karnal, AIIMS, New Delhi, India.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra
authors.affiliation: Department of Endocrinology, AIIMS, New Delhi, India.
authors.forename: Yashdeep
authors.initials: Y
authors.lastname: Gupta
mesh_terms: D015190:Blood Glucose Self-Monitoring; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D007004:Hypoglycemic Agents
keywords: Dulaglutide, Exenatide QW, Glucagon-like peptide 1 receptor agonists (GLP1RA), Semaglutide, Omarigliptin, Trelagliptin.